Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sodium channel blockers for neuroprotection in multiple sclerosis.
Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells.
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS.
Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Mechanisms of white matter damage in multiple sclerosis.
Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development.
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis.
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Sox13 functionally complements the related Sox5 and Sox6 as important developmental modulators in mouse spinal cord oligodendrocytes.
The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
Myeloproliferative neoplasms in five multiple sclerosis patients.
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
Medical image. Neuromyelitis optica masquerading as sepsis.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »